WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnershipStatistics
Pfizer earnings were $7.8B for the trailing 12 months ending Dec 31, 2025, with -3.5% growth year over year. The latest PFE earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$1.6B, down 146.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PFE reported annual earnings of $7.8B, with -3.2% growth. The next PFE earnings date is Apr 28, 2026.

PFE past earnings growth

How has PFE's earnings growth performed historically?

Company
-3.52%
Industry
138.56%
Market
86.1%
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PFE's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PFE's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PFE earnings history

Current Revenue
$62.6B
Current Earnings
$7.8B
Current Profit Margin
12.4%
PFE's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PFE Return on Equity

Current Company
8.7%
Current Industry
8.1%
Current Market
29.6%
PFE's Return on Equity (8.7%)... subscribe to Premium to read more.
High Return on Equity Performance

PFE Return on Assets

Current Company
3.7%
Current Industry
12.7%
PFE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PFE announces earnings.

PFE Return on Capital Employed

Current Company
4.38%
Current Industry
21.7%
PFE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PFE vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PFE$14.10B$7.77B-3.65%$1.37
GILD$13.58B$8.51B+132.82%$6.84
BMY$13.34B$7.05B+2.45%$3.47
GSK$10.17B$7.72B-0.73%$3.81
SNY$17.97B$9.30B-8.84%$3.81
View Top General Drug Manufacturer Stocks

PFE earnings dates

Next earnings date
Apr 28, 2026

Pfizer Earnings Reports & History FAQ

What were Pfizer's earnings last quarter?

On PFE's earnings call on Invalid Date, Pfizer (NYSE: PFE) reported Q4 2025 earnings per share (EPS) of -$0.29, up 514.29% year over year. Total PFE earnings for the quarter were -$1.65 billion. In the same quarter last year, Pfizer's earnings per share (EPS) was $0.07.

If you're new to stock investing, here's how to buy Pfizer stock.

When does Pfizer report earnings?

The next PFE earnings date is Invalid Date. Add PFE to your watchlist to be reminded of Pfizer's next earnings date.

Is Pfizer profitable or losing money?

As of the last Pfizer earnings report, Pfizer is currently profitable. Pfizer's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $7.77 billion, a 3.24% decrease year over year.

What was PFE's earnings growth in the past year?

As of Pfizer's earnings date in Invalid Date, Pfizer's earnings has grown -3.52% year over year. This is 142.08 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 138.56%. PFE earnings in the past year totalled $7.77 billion.

What are Pfizer's earnings expectations?

The current EPS estimate for Pfizer's earnings report in Invalid Date is $0.73.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.